BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for March 15, 2022

March 15, 2022
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Caredx, Celltrion, CMR Surgical, Fist Assist, Google, Limflow, Meditech, Natera, Reddress, Regional Health Care Group, Unidoc, Vivasure.
Read More

Other news to note for March 15, 2022

March 15, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Almirall, Ascletis, Biogen, Biomed, Eisai, Enochian, Eyenovia, Gain, Iaso, Imugene, Innovation, Krystal, Merck, Ovid, Passage, Periphagen, Scripps Research, University of Michigan.
Read More

Other news to note for March 14, 2022

March 14, 2022
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apyx Medical, Glaukos, Glucotrack, Happify, Medtech Acquisition, Memic, Neuro-Sysmed, Otivio, Realm Idx, Safe Group, Sophia Genetics, Zuellig.
Read More

Other news to note for March 14, 2022

March 14, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aikido, Aikomi, Altamira, Arctoris, Arena, Ascletis, ATCC, Avadel, Bright Minds, Catalyst, Calliditas, Chemomab, Concert, Enzolytics, Evariste Technologies, Everest Medicines, Gelmedix, HTL, Ideaya, Index, Kye, Liminal, Neubase, Neximmune, Nuclixbio, Oncoarendi, Pharmabcine, Pfizer, Sandoz, Siwa, Small, Sumitomo Dainippon, Synthetic Biologics, VCN Terran, Virogentics.
Read More

Other news to note for March 11, 2022

March 11, 2022
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Audere, Medical Diagnostech, Nexstim, Royal Philips.
Read More

Other news to note for March 11, 2022

March 11, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Caris, Constellation, EPI, Gedeon Richter, GT, Inomagen, Insilico, KBI, Mitocarex, Morphosys, Novan, Oragenics, Orphazyme, Pyramid, Regen, Scisparc, Tiziana.
Read More

Poseida Therapeutics reports progress across nonclinical programs

March 11, 2022

Morningside Ventures launches Adiso Therapeutics focused on inflammatory diseases

March 11, 2022

Viridian Therapeutics offers update on nonclinical pipeline

March 11, 2022

Aligos advances early-stage programs

March 11, 2022
Previous 1 2 … 254 255 256 257 258 259 260 261 262 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing